GENE ONLINE|News &
Opinion
Blog

IPO
Galderma’s Strong European IPO Debut
2024-03-26
Chinese Biotechs Seeks IPO Growth on US Shores
2024-03-13
Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evolving Market Dynamics
2024-03-12
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
Exploring AI’s Impact on Biotech Breakthroughs and International Funding
2023-08-29
A Multi-Billion Budding Venture in Consumer Health, J&J’s Kenvue Aims to Raise $3.5 Billion in IPO
2023-04-27
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Vertex Is Looking to Become Singapore’s First SPAC
2022-01-10
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
1 2 3 4
LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top